Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
This report contains market size and forecasts of Oral Contraceptive Drugs in global, including the following market information:
- Global Oral Contraceptive Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Oral Contraceptive Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Oral Contraceptive Drugs companies in 2021 (%)
The global Oral Contraceptive Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Long-acting Contraceptives Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Contraceptive Drugs include Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S and ZiZhu, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Contraceptive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Contraceptive Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Oral Contraceptive Drugs Market Segment Percentages, by Type, 2021 (%)
- Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Global Oral Contraceptive Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Oral Contraceptive Drugs Market Segment Percentages, by Application, 2021 (%)
Global Oral Contraceptive Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Oral Contraceptive Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Oral Contraceptive Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Oral Contraceptive Drugs revenues share in global market, 2021 (%)
- Key companies Oral Contraceptive Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Oral Contraceptive Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Pfizer
- Teva Pharmaceutical
- Merck
- Actavis
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
